Practical protocols for production of very high yields of recombinant proteins using Escherichia coli.
about
Structural basis for sequence specific DNA binding and protein dimerization of HOXA13Mycobacterium tuberculosis RNA Polymerase-binding Protein A (RbpA) and Its Interactions with Sigma FactorsThe actinobacterial transcription factor RbpA binds to the principal sigma subunit of RNA polymeraseSelectivity of Ni(II) and Zn(II) binding to Sporosarcina pasteurii UreE, a metallochaperone in the urease assembly: a calorimetric and crystallographic studyA structural ensemble of a ribosome-nascent chain complex during cotranslational protein folding.The La-related protein 1-specific domain repurposes HEAT-like repeats to directly bind a 5'TOP sequenceMolecular insights into the interaction between Plasmodium falciparum apical membrane antigen 1 and an invasion-inhibitory peptideEscherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs)(1)H, (13)C and (15)N resonance assignments and secondary structure analysis of translation initiation factor 1 from Pseudomonas aeruginosaSolution structure of protein synthesis initiation factor 1 from Pseudomonas aeruginosa.Optimization of overexpression of a chaperone protein of steroid C25 dehydrogenase for biochemical and biophysical characterization.Conformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formationNMR-based Structural Analysis of Threonylcarbamoyl-AMP Synthase and Its Substrate Interactions.High Yield of Recombinant Protein in Shaken E. coli Cultures with Enzymatic Glucose Release Medium EnPresso B.Modular Architecture and Unique Teichoic Acid Recognition Features of Choline-Binding Protein L (CbpL) Contributing to Pneumococcal PathogenesisEnhanced expression and purification of fungal galactose oxidase in Escherichia coli and use for analysis of a saturation mutagenesis library.Efficient condensed-phase production of perdeuterated soluble and membrane proteinsGlycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coliProduction and purification of human Hsp90β in Escherichia coli.Expression, isolation, and purification of soluble and insoluble biotinylated proteins for nerve tissue regeneration.Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligandsGlucose uptake regulation in E. coli by the small RNA SgrS: comparative analysis of E. coli K-12 (JM109 and MG1655) and E. coli B (BL21).Recombinant protein expression in Escherichia coli: advances and challengesAuto-induction medium containing glyphosate for high-level incorporation of unusual aromatic amino acids into proteins.Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic useProduction of low-expressing recombinant cationic biopolymers with high purity.Oligomer formation of tau protein hyperphosphorylated in cells.Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli.Transmembrane and Juxtamembrane Structure of αL Integrin in Bicelles.High-level expression of Bacillus naganoensis pullulanase from recombinant Escherichia coli with auto-induction: effect of lac operatorEngineering a hydroxysteroid dehydrogenase to improve its soluble expression for the asymmetric reduction of cortisone to 11β-hydrocortisone.Small molecule inhibition of the Na(+)/H(+) exchange regulatory factor 1 and parathyroid hormone 1 receptor interaction.A novel methodology for enhanced and consistent heterologous expression of unmodified human cytochrome P450 1B1 (CYP1B1).Characterization of Three Venom Peptides from the Spitting Spider Scytodes thoracica.Production of Recombinant Antimicrobial Polymeric Protein Beta Casein-E 50-52 and Its Antimicrobial Synergistic Effects Assessment with Thymol.Disorder prediction-based construct optimization improves activity and catalytic efficiency of Bacillus naganoensis pullulanase.Expression and purification of toxic anti-breast cancer p28-NRC chimeric proteinCharacterizing PvARP, a novel Plasmodium vivax antigen.High-level Expression and Purification of Active Human FGF-2 in Escherichia coli by Codon and Culture Condition Optimization.Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity
P2860
Q27325742-69C6868E-99C3-483D-A07F-9E4919491C34Q27677177-A908092A-FBFA-4077-9F37-08D16B931FB8Q27677480-AA8D7C63-ECE7-4809-AB4A-AEAB7ED0CFA4Q27687173-C34F4D8E-5654-4C3D-A641-636B2F623318Q27704200-66ED55AE-872C-438F-8108-A6508F3D577EQ28114864-2BEDF2A8-375B-45A5-A2BA-2B520E1AEA1CQ28544106-B9C6AE8D-1B42-4D70-B1DA-CC1C6238EFA8Q28550270-165D8166-51D1-4CB7-9CA3-5E1E3056EFF7Q28829977-A2C551D9-FECB-4D04-9FF9-4A24848DB239Q30152725-DF3025C7-5985-4B91-80E2-8B112D9F1C36Q30252864-185E47BB-FC65-432F-BEC0-A9DB5AAD7AFAQ30357995-2C32A4F5-B6F5-4316-9D41-7B2110990DD6Q30375501-AE45399D-6E0E-4313-AF0B-939E946FDBECQ30401653-94DFF7CD-7D0D-48EB-A3AE-1FF68924A6EEQ30830779-0BC44104-F707-401F-8D3B-0FFDB40201CEQ30996981-E2136899-5F33-476B-9FD3-04BAA13628F5Q33545267-8E4EA7ED-C919-4D48-9FE7-281F7A8FA610Q33645142-BDB3D0FF-48A8-4B48-B349-E444357ABBD6Q33834707-D3CE5546-0139-498C-9F42-0B5F70677BD4Q33872665-9F2929B2-DF80-4F64-B75E-1F0A235785D1Q33906000-95B925F2-22D3-4798-AF28-6ED9A7FF1A21Q34202709-4E9CBEC9-F160-4769-9135-21BC47885A5CQ34421339-4D1BD548-DA7C-46CD-B699-FD6969B331D7Q34501937-032CF060-8F1D-4940-9735-7C535B378BD8Q34503960-A3C4D0EE-B6AF-4120-BDAA-45E04046BA64Q34553603-336D8D1A-3950-4038-9920-5A8E121FD14FQ34634346-FD439D8F-D9ED-41E9-84E6-DCBB8C58294CQ34718440-B87F1B9D-E8CF-4F39-BFEE-779CAAE3AC4DQ34999087-64F59722-3225-4669-AF4A-1EAB326C1763Q35032570-B2AA22F4-E7B2-4B3E-8319-BE2CAA16D524Q35216774-9A3EA9B5-E5E5-4939-9323-C04E1F9C3ED7Q35235024-9A1FEF7E-15DA-437F-B9CE-9AF15B80C405Q35349314-E55D90C4-1C49-4137-AB7A-3ADFB3C3D6A4Q36030423-FD5FD6C7-F85F-45BD-B751-CBF28B77D209Q36386082-59A59AF5-8AFA-4F8D-AEBA-2499C36AAA6FQ36810152-2C416607-8362-4F97-B342-30CFFC9F65E9Q36861349-CBD3CCC5-6CF5-4103-B9FC-AD18493C3731Q36871118-1726BF41-7292-459F-8753-F2A25DDF82EAQ36890616-F6BE2A7A-2D8F-4E6F-879A-F841F1526C6EQ36977623-CD14D5D6-60B0-45C8-89BA-68E6F1437E85
P2860
Practical protocols for production of very high yields of recombinant proteins using Escherichia coli.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Practical protocols for produc ...... oteins using Escherichia coli.
@en
Practical protocols for produc ...... oteins using Escherichia coli.
@nl
type
label
Practical protocols for produc ...... oteins using Escherichia coli.
@en
Practical protocols for produc ...... oteins using Escherichia coli.
@nl
prefLabel
Practical protocols for produc ...... oteins using Escherichia coli.
@en
Practical protocols for produc ...... oteins using Escherichia coli.
@nl
P2093
P2860
P356
P1433
P1476
Practical protocols for produc ...... oteins using Escherichia coli.
@en
P2093
Arun Sivashanmugam
Chunxian Cui
Jianjun Wang
Qianqian Li
Victoria Murray
Yonghong Zhang
P2860
P304
P356
10.1002/PRO.102
P577
2009-05-01T00:00:00Z